Cure My Disease

Don't miss your cure!

Home News Browse About
Log in / Sign up
← Back to home

King George's Medical University

Clinical trials sponsored by King George's Medical University, explained in plain language.

Not yet recruiting 2
Sort by
  • Can a simple protein infusion prevent deadly Re-Bleeding in cirrhosis patients?

    Disease control Not yet recruiting

    This phase 3 trial tests whether adding albumin to standard treatment reduces re-bleeding and death in adults with cirrhosis who have acute variceal bleeding. Sixty participants will be randomly assigned to receive either albumin for three days plus standard care, or standard car…

    Phase: PHASE3 • Sponsor: King George's Medical University • Aim: Disease control

    Last updated Jun 27, 2026 09:03 UTC

  • New acid blocker may beat standard drug for Post-Banding ulcers in cirrhosis

    Prevention Not yet recruiting

    This phase 3 trial tests whether vonoprazan, a newer acid-blocking drug, is better than rabeprazole at preventing ulcers and bleeding after endoscopic variceal band ligation (EVL) in people with cirrhosis. About 300 adults with esophageal varices will take one of the two drugs da…

    Phase: PHASE3 • Sponsor: King George's Medical University • Aim: Prevention

    Last updated Jun 27, 2026 12:37 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space